← All trials
NCT03140527
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 10, 2017
- Primary completion
- Jul 25, 2017
- Completion date
- Jul 25, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 60
- Arms / groups
- 5 / —
- Source
- AACT · pre-existing
Sponsors
- Proteostasis TherapeuticsLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.